Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non–Vitamin K Antagonist Oral Anticoagulants Preceding Stroke

BACKGROUND AND PURPOSE—: Although there are no trials or large cohorts to inform clinical care, current guidelines caution against giving intravenous tPA (tissue-type plasminogen activator) to patients with acute ischemic stroke who are taking non–vitamin K antagonist oral anticoagulants (NOACs). We...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stroke
Autors principals: Jin, Chen, Huang, Ryan J., Peterson, Eric D., Laskowitz, Daniel T., Hernandez, Adrian F., Federspiel, Jerome J., Schwamm, Lee H., Bhatt, Deepak L., Smith, Eric E., Fonarow, Gregg C., Xian, Ying
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6706353/
https://ncbi.nlm.nih.gov/pubmed/30354981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.118.022128
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars